comparemela.com

Latest Breaking News On - Drug administration for emergency use authorization - Page 8 : comparemela.com

OraSure Technologies, Inc Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

OraSure Technologies, Inc Announces First Quarter 2021 Financial Results and Provides COVID-19 Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Romark s investigational Covid-19 drug lowers disease progression in trial

Romark’s investigational Covid-19 drug lowers disease progression in trial 15th April 2021 (Last Updated April 15th, 2021 17:33) Romark has reported that initial results from a Phase III clinical trial of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets, 300mg) demonstrated to reduce disease progression in mild or moderate Covid-19 patients. The trial enrolled 1,092 subjects aged 12 years and above with respiratory symptoms consistent with Covid-19. Credit: Ewa Urban from Pixabay. Share Article Romark has reported that initial results from a Phase III clinical trial of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets, 300mg) demonstrated to reduce disease progression in mild or moderate Covid-19 patients.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.